San Antonio Business Journal: Alamo City research contributes to potential new COVID vaccine
June 15, 2021
Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-1 …
KSAT 12: COVID-19 vaccine can be taken at same time, within 14 days of other vaccines, CDC says
June 15, 2021
Dr. Ruth Berggren, Infectious Diseases, Center for Medical Humanities and Ethics, spoke to KSAT 12 TV audiences on the topic that the COVID-19 vaccine can be taken at the same time as other vaccines, according to the CDC. Watch the story.
Voelcker Fund supports cancer research and discovery at UT Health San Antonio
June 15, 2021
The Max and Minnie Tomerlin Voelcker Fund is awarding $800,000 to UT Health San Antonio to support research projects conducted by promising early career researchers.
Novavax vaccine is highly protective against COVID-19 in Phase 3 results
June 14, 2021
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Elizabeth Allen, 210-358-2344, elizabeth.allen@uhs-sa.com SAN ANTONIO (June 14, 2021) — Researchers at UT Health San Antonio are buoyed by today’s news that the Novavax vaccine is strongly effectiv …
KENS 5: CDC to hold emergency meeting after vaccine concerns
June 14, 2021
Dr. Jason Bowling, Infectious Diseases, appeared in this KENS 5 story about the CDC’s plan to hold an emergency meeting to discuss COVID-19 vaccine concerns involving heart inflammation, mainly in teenage boys and young men. Watch the story.
News 4: UT Health San Antonio researchers discover how COVID can hide in the body
June 14, 2021
Dr. Yogesh Gupta, Biochemistry/Structural Biology/Greehey Children’s Cancer Research Institute, spoke to News 4 San Antonio on the topic of the recent published findings in Nature Communications about the COVID-19 virus using metal ions, like magnesium …
Targeted Oncology: Transfusion independence at 24 weeks linked to improved OS on momelotinib in myelofibrosis
June 11, 2021
Dr. Ruben Mesa, executive director of the Mays Cancer Center, is quoted in this Targeted Oncology story. Read the story.
KSAT 12: Q&A: Infectious disease Dr. Ruth Berggren discusses delta COVID-19 variant in Texas
June 11, 2021
Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities and Ethics, participated in a KSAT 12 Q & A with anchor Steve Spriester, discussing delta COVID-19 variant in Texas. Watch the Q&A.
Spectrum News: $9.8M study will follow 3,000 Latino cancer survivors
June 11, 2021
Dr. Amelie Ramirez, Institute for Health Promotion Research, Salud America!, Population Health Sciences, Mays Cancer Center, was interviewed by Spectrum News about a $9.8 million study focused on the Latino cancer survivorship experience. Watch the sto …
Study will compare 2 treatment strategies for severe brain injury; public comment requested
June 10, 2021
Editor’s note: This story, originally posted on June 10, 2020, is being reposted to include a link to this anonymous survey: http://bit.ly/BOOST3CommunitySurvey. The public comment phase leading up to the study is nearly complete, and feedback is welco …